214 related articles for article (PubMed ID: 28882945)
1. Melatonin Synergizes the Chemotherapeutic Effect of Cisplatin in Ovarian Cancer Cells Independently of MT1 Melatonin Receptors.
Zemła A; Grzegorek I; Dzięgiel P; Jabłońska K
In Vivo; 2017; 31(5):801-809. PubMed ID: 28882945
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.
Treeck O; Haldar C; Ortmann O
Oncol Rep; 2006 Jan; 15(1):231-5. PubMed ID: 16328061
[TBL] [Abstract][Full Text] [Related]
3. Melatonin MT
López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
[TBL] [Abstract][Full Text] [Related]
4. Expression of the MT1 melatonin receptor in ovarian cancer cells.
Jablonska K; Pula B; Zemla A; Kobierzycki C; Kedzia W; Nowak-Markwitz E; Spaczynski M; Zabel M; Podhorska-Okolow M; Dziegiel P
Int J Mol Sci; 2014 Dec; 15(12):23074-89. PubMed ID: 25514412
[TBL] [Abstract][Full Text] [Related]
5. Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity.
Barberino RS; Menezes VG; Ribeiro AEAS; Palheta RC; Jiang X; Smitz JEJ; Matos MHT
Biol Reprod; 2017 Jun; 96(6):1244-1255. PubMed ID: 28595266
[TBL] [Abstract][Full Text] [Related]
6. Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro.
Winczyk K; Fuss-Chmielewska J; Lawnicka H; Pawlikowski M; Karasek M
Neuro Endocrinol Lett; 2009; 30(5):657-62. PubMed ID: 20035258
[TBL] [Abstract][Full Text] [Related]
7. Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells.
Kim JH; Jeong SJ; Kim B; Yun SM; Choi DY; Kim SH
J Pineal Res; 2012 Mar; 52(2):244-52. PubMed ID: 22050627
[TBL] [Abstract][Full Text] [Related]
8. The Regulatory Mechanism of MLT/MT1 Signaling on the Growth of Antler Mesenchymal Cells.
Yang F; He C; Sun X; Wang J; Luo C; Liu G; Yang L; Xiong J; Huo L
Molecules; 2017 Oct; 22(10):. PubMed ID: 29065543
[TBL] [Abstract][Full Text] [Related]
9. Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.
Carbajo-Pescador S; García-Palomo A; Martín-Renedo J; Piva M; González-Gallego J; Mauriz JL
J Pineal Res; 2011 Nov; 51(4):463-71. PubMed ID: 21718361
[TBL] [Abstract][Full Text] [Related]
10. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B
J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981
[TBL] [Abstract][Full Text] [Related]
11. Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin.
Hill SM; Cheng C; Yuan L; Mao L; Jockers R; Dauchy B; Frasch T; Blask DE
Breast Cancer Res Treat; 2011 May; 127(1):91-8. PubMed ID: 20549340
[TBL] [Abstract][Full Text] [Related]
12. Age-related decline in melatonin and its MT1 receptor are associated with decreased sensitivity to melatonin and enhanced mammary tumor growth.
Hill SM; Cheng C; Yuan L; Mao L; Jockers R; Dauchy B; Blask DE
Curr Aging Sci; 2013 Feb; 6(1):125-33. PubMed ID: 23895529
[TBL] [Abstract][Full Text] [Related]
13. Growth-inhibitory activity of melatonin on murine foregastric carcinoma cells in vitro and the underlying molecular mechanism.
Xu L; Liu H; Zhang H; Wang RX; Song J; Zhou RX
Anat Rec (Hoboken); 2013 Jun; 296(6):914-20. PubMed ID: 23564716
[TBL] [Abstract][Full Text] [Related]
14. [MT1 melatonin receptors and their role in the oncostatic action of melatonin].
Danielczyk K; Dziegiel P
Postepy Hig Med Dosw (Online); 2009 Sep; 63():425-34. PubMed ID: 19837985
[TBL] [Abstract][Full Text] [Related]
15. Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation.
Cucielo MS; Cesário RC; Silveira HS; Gaiotte LB; Dos Santos SAA; de Campos Zuccari DAP; Seiva FRF; Reiter RJ; de Almeida Chuffa LG
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889222
[TBL] [Abstract][Full Text] [Related]
16. Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light-dark cycle.
Domínguez-López S; Mahar I; Bambico FR; Labonté B; Ochoa-Sánchez R; Leyton M; Gobbi G
J Psychopharmacol; 2012 Jun; 26(6):830-44. PubMed ID: 21730015
[TBL] [Abstract][Full Text] [Related]
17. Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line.
Watanabe M; Kobayashi Y; Takahashi N; Kiguchi K; Ishizuka B
J Obstet Gynaecol Res; 2008 Aug; 34(4):567-73. PubMed ID: 18937711
[TBL] [Abstract][Full Text] [Related]
18. Effect of melatonin on the oxidative stress in N1E-115 cells is not mediated by mt1 receptors.
Montilla P; Feijóo M; Muñoz MC; Muñoz-Castañeda JR; Bujalance I; Túnez I
J Physiol Biochem; 2003 Dec; 59(4):263-8. PubMed ID: 15164945
[TBL] [Abstract][Full Text] [Related]
19. Melatonin Promotes Antler Growth by Accelerating MT1-Mediated Mesenchymal Cell Differentiation and Inhibiting VEGF-Induced Degeneration of Chondrocytes.
Sun X; Gu X; Li K; Li M; Peng J; Zhang X; Yang L; Xiong J
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054949
[TBL] [Abstract][Full Text] [Related]
20. Melatonin antagonizes oxidative stress-induced mitochondrial dysfunction in retinal pigmented epithelium cells via melatonin receptor 1 (MT1).
Yan G; Yu L; Jiang S; Zhu J
J Toxicol Sci; 2018; 43(11):659-669. PubMed ID: 30404999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
